Drugs / CD34+
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01856582 | Oct 2010 → Aug 2018 | bone marrow failure syndrome, immunodeficiency disease | Children's Hospital Medical Center, Cincinnati | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01856582 ↗ |
| Modality | Cell therapy | “An infusion of selected CD34+ stem cells will be given without any preparative regimen.” NCT01856582 ↗ |